Rohto Pharmaceutical Co.,Ltd. (4527.T)

JPY 2680.5

(0.11%)

Market Cap (In JPY)

611.52 Billion

Revenue (In JPY)

270.84 Billion

Net Income (In JPY)

30.93 Billion

Avg. Volume

705.92 Thousand

Currency
JPY
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
2638.0-3688.0
PE
-
EPS
-
Beta Value
-0.205
ISIN
JP3982400008
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Mr. Yamada Kunio
Employee Count
-
Website
https://www.rohto.co.jp
Ipo Date
2001-01-04
Details
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.